These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10580834)

  • 1. Androgens decrease and retinoids increase the expression of insulin-like growth factor-binding protein-3 in LNcaP prostatic adenocarcinoma cells.
    Goossens K; Esquenet M; Swinnen JV; Manin M; Rombauts W; Verhoeven G
    Mol Cell Endocrinol; 1999 Sep; 155(1-2):9-18. PubMed ID: 10580834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoids stimulate lipid synthesis and accumulation in LNCaP prostatic adenocarcinoma cells.
    Esquenet M; Swinnen JV; Van Veldhoven PP; Denef C; Heyns W; Verhoeven G
    Mol Cell Endocrinol; 1997 Dec; 136(1):37-46. PubMed ID: 9510066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LNCaP prostatic adenocarcinoma cells derived from low and high passage numbers display divergent responses not only to androgens but also to retinoids.
    Esquenet M; Swinnen JV; Heyns W; Verhoeven G
    J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):391-9. PubMed ID: 9449242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1alpha,25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate.
    Esquenet M; Swinnen JV; Heyns W; Verhoeven G
    Prostate; 1996 Mar; 28(3):182-94. PubMed ID: 8628721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of insulin-like growth factor binding protein-3 in the growth inhibitory actions of androgens in LNCaP human prostate cancer cells.
    Peng L; Wang J; Malloy PJ; Feldman D
    Int J Cancer; 2008 Feb; 122(3):558-66. PubMed ID: 17918155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells.
    Stewart LV; Weigel NL
    Prostate; 2005 Jun; 64(1):9-19. PubMed ID: 15651061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor binding protein-3 and -5 are regulated by transforming growth factor-beta and retinoic acid in the human prostate adenocarcinoma cell line PC-3.
    Hwa V; Oh Y; Rosenfeld RG
    Endocrine; 1997 Jun; 6(3):235-42. PubMed ID: 9368678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triiodothyronine modulates growth, secretory function and androgen receptor concentration in the prostatic carcinoma cell line LNCaP.
    Esquenet M; Swinnen JV; Heyns W; Verhoeven G
    Mol Cell Endocrinol; 1995 Mar; 109(1):105-11. PubMed ID: 7540569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgens down-regulate the expression of the human homologue of paternally expressed gene-3 in the prostatic adenocarcinoma cell line LNCaP.
    Ulrix W; Swinnen JV; Heyns W; Verhoeven G
    Mol Cell Endocrinol; 1999 Sep; 155(1-2):69-76. PubMed ID: 10580840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibitory concentrations of androgens up-regulate insulin-like growth factor binding protein-3 expression via an androgen response element in LNCaP human prostate cancer cells.
    Peng L; Malloy PJ; Wang J; Feldman D
    Endocrinology; 2006 Oct; 147(10):4599-607. PubMed ID: 16825320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells.
    Ikezoe T; Tanosaki S; Krug U; Liu B; Cohen P; Taguchi H; Koeffler HP
    Blood; 2004 Jul; 104(1):237-42. PubMed ID: 15026318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of insulin-like growth factor-binding protein-related proteins (IGFBP-rPs) 1, 2, and 3 in human prostate epithelial cells: potential roles for IGFBP-rP1 and 2 in senescence of the prostatic epithelium.
    López-Bermejo A; Buckway CK; Devi GR; Hwa V; Plymate SR; Oh Y; Rosenfeld RG
    Endocrinology; 2000 Nov; 141(11):4072-80. PubMed ID: 11089538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
    Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G
    Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor binding protein-3 prevents retinoid receptor heterodimerization: implications for retinoic acid-sensitivity in human breast cancer cells.
    Schedlich LJ; O'Han MK; Leong GM; Baxter RC
    Biochem Biophys Res Commun; 2004 Jan; 314(1):83-8. PubMed ID: 14715249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the human prostatic adenocarcinoma cell line LNCaP.
    Swinnen JV; Esquenet M; Heyns W; Rombauts W; Verhoeven G
    Mol Cell Endocrinol; 1994 Sep; 104(2):153-62. PubMed ID: 7527352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoic acid increases insulin-like growth factor-binding protein-4 expression in cultured rat hepatocytes.
    Demori I; Balocco S; Gerdoni E; Fugassa E; Voci A
    Horm Metab Res; 2004 Jan; 36(1):7-13. PubMed ID: 14983400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
    Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R
    Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
    Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors.
    Kiyama S; Morrison K; Zellweger T; Akbari M; Cox M; Yu D; Miyake H; Gleave ME
    Cancer Res; 2003 Jul; 63(13):3575-84. PubMed ID: 12839944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.